Zimmer Biomet Holdings (ZBH) has been under a strong bear grip, hence the stock is down -1.04% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 2.02% in the past 1 week. The stock has risen by 1.35% in the past week indicating that the buyers are active at lower levels, but the stock is down -1.24% in the past 4 weeks.
For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 0.14% and the fifty day Moving Average is 3.6%. Zimmer Biomet Holdings, Inc. is up 5.45% in the last three month period. Year-to-Date the stock performance stands at 26.79%.
Zimmer Biomet Holdings (ZBH) : The most positive equity analysts on Zimmer Biomet Holdings (ZBH) expects the shares to touch $155, whereas, the least positive believes that the stock will trade at $120 in the short term. The company is covered by 15 Wall Street Brokerage Firms. The average price target for shares are $142.47 with an expected fluctuation of $10.06 from the mean.
Zimmer Biomet Holdings (NYSE:ZBH): stock turned positive on Friday. Though the stock opened at $128.6, the bulls momentum made the stock top out at $129.68 level for the day. The stock recorded a low of $127.64 and closed the trading day at $129.51, in the green by 1.05%. The total traded volume for the day was 1,379,038. The stock had closed at $128.16 in the previous days trading.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.